When should respiratory physicians consider lung transplantation for their patients? Inscription criteria for the national waiting list;Quand le pneumologue doit-il envisager la greffe pulmonaire pour un de ses patients? Critères d'inscription en liste d'attente: Mucoviscidose, HTAP et maladies systémiques (sarcoïdose, histiocytose langerhansienne, lymphangioleïomyomatose et connectivites)

Revue des Maladies Respiratoires

Volumn 26, Issue 4, 2009, Pages 423-435

  Philippe, B ^a   Dromer, C ^b   Mornex, J F ^c   Velly, J F ^b   Stern, M ^a  

^a FOCH HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

Connective tissue disease; Cystic fibrosis; Lung transplantation; Pulmonary hypertension; Sarcoidosis; Waiting list

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; INSULIN; PANCRELIPASE; PROSTACYCLIN; SILDENAFIL;

ANTIBIOTIC THERAPY; BRONCHITIS; CLINICAL DECISION MAKING; CONNECTIVE TISSUE DISEASE; CYSTIC FIBROSIS; DIABETES MELLITUS; DYSPNEA; EXPERIENCE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTIOCYTOSIS X; HOSPITAL ADMISSION; HUMAN; HYPERCAPNIA; HYPOXEMIA; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MONOTHERAPY; OSTEOPOROSIS; PERIOPERATIVE PERIOD; PHYSICIAN; POSTOPERATIVE COMPLICATION; PREDICTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; VITAMIN SUPPLEMENTATION; ARTICLE; DECISION MAKING; LUNG DISEASE; PATIENT SELECTION;

DECISION MAKING; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PATIENT SELECTION; WAITING LISTS;

EID: 68049084645     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(09)74047-1     Document Type: Review

References (85)

1. Stern M, Souilamas R, Tixier D, Mal H : Transplantation pulmonaire : la satisfaction des besoins en France. Rev Mal Respir 2008 ; 25 : 953-965
2. Reynaud-Gaubert M, Boniface S, Metivier AC, Kessler R : Quand le pneumologue doit-il envisager la greffe pulmonaire pour un de ses patients adulte ? Indications, critères de sélection, préparation à la greffe. Rev Mal Respir 2008 ; 25 : 1251-1259
3. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI : Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 ; 26 : 782-795 (Pubitemid 47199080)
4. De Meester J, Smits JM, Persijn GG, Haverich A : Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001 ; 20 : 518-524 (Pubitemid 32410013)
5. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ : Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998 ; 351 : 24-27 (Pubitemid 28020162)
6. Liou TG, Adler FR, Cox DR, Cahill BC : Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007 ; 357 : 2143-2152 (Pubitemid 350146109)
7. Sweet SC, Aurora P, Benden C, Wong JY, Goldfarb SB, Elidemir O, Woo MSMallory GB, Jr : Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008 ; 12 : 129-136 (Pubitemid 351326934)
8. Stern M, Reynaud-Gaubert M, Haloun A, Bertocchi MGrenet D : Transplantation pulmonaire dans la mucoviscidose de l'adulte : critères de sélection des patients. Rev Mal Respir 2000 ; 17 : 779-784
9. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR : International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998 ; 66 : 951-956
10. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, Martinez FJ, Nathan S, Palmer S, Patterson A, Singer L, Snell G, Studer S, Vachiery JL, Glanville AR : International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 ; 25 : 745-755
11. Hadjiliadis D : Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 2007 ; 131 : 1224-1231 (Pubitemid 46608728)
12. Kerem E, Reisman J, Corey M, Canny GJ, Levison H : Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992 ; 326 : 1187-1191
13. Belkin RA, Henig NR, Singer LG, Chaparro C, Rubenstein RC, Xie SX, Yee JY, Kotloff RM, Lipson DA, Bunin GR : Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006 ; 173 : 659-666 (Pubitemid 43363808)
14. Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML : Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002 ; 166 : 1550-1555 (Pubitemid 36015948)
15. Doershuk CF, Stern RC : Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 1999 ; 115 : 782-787
16. Liou TG, Adler FR, Huang D : Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005 ; 171 : 1053-1059
17. Milla CE, Warwick WJ : Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998 ; 113 : 1230-1234
18. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP : Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004 ; 126 : 412-419 (Pubitemid 39093425)
19. Ellaffi M, Vinsonneau C, Coste J, Hubert D, Burgel PR, Dhainaut JF, Dusser D : One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med 2005 ; 171 : 158-164 (Pubitemid 40105415)
20. De Soyza A, Archer L, Wardle J, Parry G, Dark JH, Gould K, Corris PA : Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis. J Heart Lung Transplant 2003 ; 22 : 764-769 (Pubitemid 36842928)
21. Bonvillain RW, Valentine VG, Lombard G, LaPlace S, Dhillon G, Wang G : Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung Transplant 2007 ; 26 : 890-897 (Pubitemid 47369203)
22. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, Keshavjee S, Scavuzzo M, Tullis E, Hutcheon M, Kesten S : Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001 ; 163 : 43-48 (Pubitemid 32095251)
23. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR : Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993 ; 103 : 466-471 (Pubitemid 23070746)
24. Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P, Stern M : Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008 ; 63 : 732-737
25. Murray S, Kawut S : Defining transplantation and listing benefit in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 ; 177 : 1054-1055 (Pubitemid 351717560)
26. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA : Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001 ; 358 : 1780-1781 (Pubitemid 33153006)
27. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH : Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001 ; 164 : 2102-2106 (Pubitemid 34023582)
28. Alexander BD, Petzold EW, Reller LB, Palmer SM, Davis RD, Woods CW, Lipuma JJ : Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008 ; 8 : 1025-1030
29. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, Tomashefski J, Knowles MR : Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003 ; 167 : 835-840 (Pubitemid 36801770)
30. Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP, Paradowski LJ, Aris RM : Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006 ; 61 : 507-513 (Pubitemid 43901521)
31. Chernenko SM, Humar A, Hutcheon M, Chow CW, Chaparro C, Keshavjee S, Singer LG : Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006 ; 25 : 1447-1455 (Pubitemid 44909461)
32. Nash KL, Collier JD, French J, McKeon D, Gimson AE, Jamieson NV, Wallwork J, Bilton D, Alexander GJ : Cystic fibrosis liver disease: to transplant or not to transplant? Am J Transplant 2008 ; 8 : 162-169
33. Barshes NR, DiBardino DJ, McKenzie ED, Lee TC, Stayer SA, Mallory GB, Karpen SJ, Quiros-Tejeira RE, Carter BA, Fraser CD, Jr.Goss JA : Combined lung and liver transplantation: the United States experience. Transplantation 2005; 80 : 1161-1167 (Pubitemid 41746791)
34. Couetil JP, Soubrane O, Houssin DP, Dousset BE, Chevalier PG, Guinvarch A, Loulmet D, Achkar A, Carpentier AF : Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997 ; 10 : 33-39 (Pubitemid 26413388)
35. Hecker TM, Aris RM : Management of osteoporosis in adults with cystic fibrosis. Drugs 2004 ; 64 : 133-147 (Pubitemid 38186962)
36. Trulock EP : Lung transplantation. Am J Respir Crit Care Med 1997 ; 155 : 789-818.
37. Dosanjh A : A review of nutritional problems and the cystic fibrosis lung transplant patient. Pediatr Transplant 2002 ; 6 : 388-391 (Pubitemid 35265188)
38. Young AC, Wilson JW, Kotsimbos TC, Naughton MT : Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax 2008 ; 63 : 72-77
39. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A : Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004 ; 43 : 5S-12S.
40. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL : Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984 ; 70 : 580-587 (Pubitemid 14020655)
41. Rich S, Brundage BH : High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation. 1987 ; 76 : 135-141 (Pubitemid 17093201)
42. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G : Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005 ; 111 : 3105-3111 (Pubitemid 40847788)
43. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE : Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982 ; 306 : 557-564
44. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS : Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994 ; 121 : 409-415
45. Conte JV, Gaine SP, Orens JB, Harris T, Rubin LJ : The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. J Heart Lung Transplant 1998 ; 17 : 679-685 (Pubitemid 28389738)
46. Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galie N, Humbert M, Rainisio M, Rubin LJ, Simonneau G : Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 2005 ; 60 : 1025-1030 (Pubitemid 41705471)
47. Dandel M, Lehmkuhl HB, Mulahasanovic S, Weng Y, Kemper D, Grauhan O, Knosalla C, Hetzer R : Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment. J Heart Lung Transplant 2007 ; 26 : 898-906. (Pubitemid 47369210)
48. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, Grover FL : Development of the new lung allocation system in the United States. Am J Transplant. 2006 ; 6 : 1212-1227
49. Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE : Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003 ; 123 : 344-350 (Pubitemid 36269414)
50. Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM : Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 2003 ; 167 : 580-586
51. Holcomb BW, Jr., Loyd JE, Ely EW, Johnson J, Robbins IM : Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000 ; 118 : 1671-1679 (Pubitemid 32001794)
52. Almagro P, Julia J, Sanjaume M, Gonzalez G, Casalots J, Heredia JL, Martinez J, Garau J : Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature. Medicine (Baltimore) 2002 ; 81 : 417-424 (Pubitemid 35285961)
53. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G : Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 ; 126 : 78S-92S. (Pubitemid 38932344)
54. Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi ELandzberg M : Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006 ; 114 : 48-54. (Pubitemid 44305274)
55. Adriaenssens T, Delcroix M, Van Deyk K, Budts W : Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome. Eur Heart J 2006 ; 27 : 1472-1477 (Pubitemid 43998082)
56. Rosenzweig EB, Kerstein D, Barst RJ : Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999 ; 99 : 1858-1865 (Pubitemid 29181415)
57. Jais X, Dartevelle P, Parent F, Sitbon O, Humbert M, Fadel E, Mussot S, Cabrol S, Le Pavec J, Sztrymf B, Tcherakian C, Musset D, Maitre S, Simonneau G : Hypertension pulmonaire postembolique. Rev Mal Respir 2007 ; 24 : 497-508.
58. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, Sitbon O, Simonneau G : Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004 ; 23 : 637-648
59. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K : Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000 ; 161 : 487-492 (Pubitemid 30129457)
60. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G : Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002 ; 40: 780-788 (Pubitemid 34925627)
61. Provencher S, Sitbon O, Humbert M, Cabrol S, Jais X, Simonneau G : Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J 2006; 27 : 589-595
62. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J : Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 ; 126 : 63S-71S. (Pubitemid 38932342)
63. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH : Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002 ; 21 : 731-737 (Pubitemid 34718178)
64. Kramer MR, Marshall SE, McDougall IR, Kloneck A, Starnes VA, Lewiston NJ, Theodore J : The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension. Transplant Proc 1991 ; 23 : 1215-1216
65. Levine SM, Jenkinson SG, Bryan CL, Anzueto A, Zamora CA, Gibbons WJ, Calhoon JH, Trinkle JK : Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992 ; 101 : 401-405
66. Boujoukos AJ, Martich GD, Vega JD, Keenan RJ, Griffith BP : Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant 1997 ; 16 : 439-448 (Pubitemid 27199601)
67. Bando K, Keenan RJ, Paradis IL, Konishi H, Komatsu K, Hardesty RL, Griffith BP : Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg 1994 ; 58 : 1336-1342 (Pubitemid 24347521)
68. Pasque MK, Kaiser LR, Dresler CM, Trulock E, Triantafillou AN, Cooper JD : Single lung transplantation for pulmonary hypertension. Technical aspects and immediate hemodynamic results. J Thorac Cardiovasc Surg 1992 ; 103 : 475-81 ; discussion 81-82
69. Chapelier A, Vouhe P, Macchiarini P, Lenot B, Cerrina J, Le Roy Ladurie F, Parquin F, Herve P, Brenot F, Lafont D : Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1993 ; 106 : 299-307. (Pubitemid 23243249)
70. Franke U, Wiebe K, Harringer W, Franke T, Wittwer T, Wahlers T, Haverich A : Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg 2000 ; 18 : 447-452
71. Nunes H, Humbert M, Capron F, Brauner M, Sitbon O, Battesti JP, Simonneau G, Valeyre D : Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006 ; 61 : 68-74. (Pubitemid 43106981)
72. Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW : Sarcoidosis-associated pulmonary hypertension: outcome with longterm epoprostenol treatment. Chest 2006 ; 130 : 1481-1488
73. Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, Kotloff RM : Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001 ; 120 : 873-880 (Pubitemid 32885463)
74. Shorr AF, Davies DB, Nathan SD : Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003 ; 124 : 922-928 (Pubitemid 37123310)
75. Shorr AF, Davies DB, Nathan SD : Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002 ; 122 : 233-238 (Pubitemid 34754168)
76. Judson MA : Lung transplantation for pulmonary sarcoidosis. Eur Respir J 1998 ; 11 : 738-744
77. Milman N, Andersen CB, Burton CM, Iversen M : Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J 2005 ; 26 : 549-552 (Pubitemid 41264219)
78. Etienne B, Bertocchi M, Gamondes JP, Thevenet F, Boudard C, Wiesendanger T, Loire R, Brune J, Mornex JF : Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998 ; 157 : 288-291 (Pubitemid 28071295)
79. Reynaud-Gaubert M, Mornex JF, Mal H, Treilhaud M, Dromer C, Quetant S, Leroy-Ladurie F, Guillemain R, Philit F, Dauriat G, Grenet D, Stern M : Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008 ; 86 : 515-520
80. Boehler A, Speich R, Russi EW, Weder W : Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996 ; 335 : 1275-1280
81. Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP : Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003; 167: 976-982 (Pubitemid 36408163)
82. Tarnow H, Herlenius G, Friman S, Olausson M, Norden G, Felldin M, Backman L : Outcome of renal transplantation subsequent to liver, heart, or lung transplantation. Transplant Proc 2006 ; 38 : 2649-2650 (Pubitemid 44693659)
83. D'Ovidio F, Mura M, Ridsdale R, Takahashi H, Waddell TK, Hutcheon M, Hadjiliadis D, Singer LG, Pierre A, Chaparro C, Gutierrez C, Miller L, Darling G, Liu M, Post M, Keshavjee S : The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006 ; 6 : 1930-1938 (Pubitemid 44024966)
84. Schachna L, Medsger TA, Jr., Dauber JH, Wigley FM, Braunstein NA, White B, Steen VD, Conte JV, Yang SC, McCurry KR, Borja MC, Plaskon DE, Orens JB, Gelber AC : Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006 ; 54 : 3954-3961 (Pubitemid 44955899)
85. Pigula FA, Griffith BP, Zenati MA, Dauber JH, Yousem SA, Keenan RJ : Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg 1997 ; 64 : 1630-1634